Skip to main content
Premium Trial:

Request an Annual Quote

OligoLibraries, Rosetta Resolver, DecisionSite 6.3 and BIOFACET


Sigma-Genosys of Houston, Texas, part of Sigma-Aldrich, and Compugen have launched OligoLibraries, genome oligonucleotide collections from the mouse, rat, and human genome for gene expression profiling. Customers of the OligoLibraries will be able to access certain gene sequences and other information through Compugen''''s LabOnWeb (


Rosetta Biosoftware of Kirkland, Wash., has released version 3.0 of the Rosetta Resolver Gene Expression Data Analysis System.

The new version includes a visualization tool called Pathway Viewer, which allows users to view gene expression data in the context of user-specified pathways. It also offers class prediction algorithms (Bayesian classifiers) to enable researchers to combine prior knowledge with observed data, as well as principal component analysis, a new pattern discovery tool, and analysis of variance.


Spotfire of Somerville, Mass., has released DecisionSite 6.3, the latest version of the modular application. Users can now query the Celera Discovery System directly from active records in DecisionSite to return homology, annotation, and reference details. In addition, the new version offers integrated access to CAS''''s SciFinder for chemical data analysis and to OSI Software''''s Plant Information System for manufacturing management.


Gene-IT of Malmaison, France, has launched BIOFACET (Fast Search and Cluster Tool), which combines the Blast algorithm with Gene-IT’s string-matching algorithms to accelerate sequence similarity searching. BIOFACET runs on any Unix platform.


GenBank release 126.0 is available from the National Center for Biotechnology Information at

Release 126.0 contains 14,396,883,064 base pairs and 13,602,262 entries—up 853.5 million base pairs and 788,746 sequence records from the August 125.0 release.



Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.